Talk Description
Associate Professor Zhichao Wu presents on Geographic Atrophy – Updates on Clinical Management in a New Era
Duration: 60 minutes
Synopsis: The management of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is rapidly changing with the regulatory approval of a new treatment in Australia, and with many promising therapies on the horizon. This session will cover updates on how we should now manage such patients in this new era.
Learning Objectives
By the end of this session, delegates should be able to:
Duration: 60 minutes
Synopsis: The management of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is rapidly changing with the regulatory approval of a new treatment in Australia, and with many promising therapies on the horizon. This session will cover updates on how we should now manage such patients in this new era.
Learning Objectives
By the end of this session, delegates should be able to:
- Describe changes to OA’s Clinical Practice Guide for AMD for managing GA
- Discuss findings from recent landmark GA treatment trials and implications for care
- Discern the usefulness of different imaging modalities for evaluating GA
Assessment: There are 10 Optional MCQS with this presentation. Not available yet.